1. HTA as evaluation of treatment with Lucentis for patients with wet AMD in the region of North Jutland, Denmark Karen Marie Poulsen, Charge nurse Department of Ophtalmology, Aalborg University Hospital

2. Some patients describe their first experience with AMD like this:

3. Aim: Changes in patients mobility and quality of life from the time of first treatment with Lucentis to 6 month after. Changes in fall risk in the period 6 month before the first treatment with Lucentis to the period 6 month after.

4. D15 score baseline and 6 month after first Lucentis

5. Risk of falling 6 month after first Lucentis: is reduced for men by 25 % is reduced for women by 67%

6. The title of the study that follows: How can a participatory rehabilitation service with focus on quality of life for patients with wet AMD be planned?

7. Aim: To investigate the perceived quality of life of the patients with wet AMD into the existing treatment and control context in Denmark To develop, intervene and investigate the importance of a participatory rehabilitation effort, which aims to preserve or enhance the quality of life of patients with wet AMD.

8. Quality of life in this context: The patient's subjective perception of how good or bad his life is in relation to the independence and meaningfullness.

9. Based on the aims the study will consist of two sub-studies: Substudy 1: qualitative interview study in which quality of life of Danes with wet AMD will be described. Subsequently this forms the basis for compiling a participatory rehabilitation services where independence and meaningfulness is the goal. Substudy 2: intervention study in which the new knowledge will be developed, prioritized and tested in practice.

10. Thank you for your attention